ClinicalMetric / Countries / Spain / pancreatic ductal adenocarcinoma
← 🇪🇸 Spain Trials
🇪🇸 Spain Country × Condition

pancreatic ductal adenocarcinoma Clinical Trials in Spain

Active clinical trials for pancreatic ductal adenocarcinoma with research sites in Spain. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 2 // Recruiting: 2 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇪🇸 Spain

Active Trials in Spain (2)

NCT07284277 Phase 1, Phase 2
Recruiting

TTFields and Chemotherapy in Metastatic Pancreatic Adenocarcinoma (mPDAC)

Enrollment
30 pts
Country
🇪🇸 Spain
Clinica Universidad de Navarra, Uni...
View Trial →
NCT07629960 Phase 1, Phase 2
Recruiting

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Enrollment
265 pts
Country
🇪🇸 Spain
Blueprint Medicines Corporation
View Trial →

Frequently Asked Questions

How many pancreatic ductal adenocarcinoma clinical trials are active in Spain?
There are currently 2 active clinical trials for pancreatic ductal adenocarcinoma with sites in Spain, of which 2 are actively recruiting patients.
How can I join a pancreatic ductal adenocarcinoma clinical trial in Spain?
To join a pancreatic ductal adenocarcinoma clinical trial in Spain, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Spain directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are pancreatic ductal adenocarcinoma trials in Spain?
Active pancreatic ductal adenocarcinoma trials in Spain span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Spain Trials → Global pancreatic ductal adenocarcinoma Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology